Search
NRX Pharmaceuticals Inc
NRXPAdd to Watchlist
3.320USD
-0.070-2.06%
Close 09-18 16:00（ET）
144.58MMarket Cap
LossP/E TTM
NRX Pharmaceuticals Inc (NRXP) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts giving stock ratings to NRX Pharmaceuticals Inc in the past month.
Buy
1 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
38.250USD+1025.00%
NRXP Analyst Recommendation Trends
In the current month, NRXP has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NRXP average Analyst price target in the last month is 38.250.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
1
1
1
1
1
1
1
1
4
4
4
4
3
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
5
5
4
4
4
4
NRXP Analyst Rating for Peer Comparison
Updated: Sep 18, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
8
13
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Ascendis Pharma A/S
ASND
10
10
0
0
0
20
Financial Forecasting
Based on analysts' estimates, NRXP EPS is projected to reach -0.014 in FY2026Q3, following reported EPS of -0.439 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.00
0.29
0.06
-0.01
0.01
Actual
0.01
-0.04
-0.44
--
--
Surprise
+597.20%
-115.39%
-785.61%
--
--
FAQs
What is NRX Pharmaceuticals Inc's expected revenue for the next quarter?
NRX Pharmaceuticals Inc's expected revenue is 17.26M.
What is NRX Pharmaceuticals Inc's price target?
Analysts forecast that NRX Pharmaceuticals Inc's price target is USD 38.25, with the highest forecast at USD 49.00 and the lowest forecast at USD 10.00.
How have NRX Pharmaceuticals IncNRXP's recent earnings per share performed?
The market expectation was USD -0.44, while NRX Pharmaceuticals IncNRXP's earnings per share (EPS) for the previous quarter was USD -0.04. EPS for the next quarter is expected at USD -0.01.
What is the analyst rating for NRX Pharmaceuticals Inc?
Based on the ratings of NRX Pharmaceuticals Inc's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.